NCT04811573View on ClinicalTrials.gov

A Study in Healthy People to Compare 3 Different Formulations of Apremilast Tablets Taken With or Without Food

PHASE1TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

August 18, 2021

Study Completion Date

August 18, 2021

Conditions
Healthy
Interventions
DRUG

EU-sourced Otezla®

Test product

DRUG

US-sourced Otezla®

Reference product 1

DRUG

Japan-sourced Otezla®

Reference product 2

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY